NASHVILLE, Tenn. (WKRN) – Vanderbilt University scientists will be allowed to proceed with an new Alzheimer’s drug clinical trial.

They received notification from the U.S. Food and Drug Administration that testing in humans may proceed after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center.